Showing results (101-110 of 257) with videos related to

Sort By:
Pageof 26
Frontiers in Oncology|December 4, 2025
GIMEMA survey on the management of chronic myeloid leukemia patients in the third line and beyond: insights from Italian hematologistsMassimo Breccia, Alfonso Piciocchi, Elisabetta Abruzzese, et al.
Cancers|July 12, 2025
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic CenterFrancesco Grimaldi, Mara Memoli, Simona Avilia, et al.
Blood|May 13, 2011
BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNetSimona Soverini, Andreas Hochhaus, Franck E Nicolini, et al.
Leukemia Research|November 28, 2013
Selective strong synergism of Ruxolitinib and second generation tyrosine kinase inhibitors to overcome bone marrow stroma related drug resistance in chronic myelogenous leukemiaConcetta Quintarelli, Biagio De Angelis, Santa Errichiello, et al.
Blood|June 7, 2003
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcomeGiuseppe Cimino, Loredana Elia, Marco Mancini, et al.
International Journal of Hematology|March 25, 2014
Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) studyMichele Baccarani, Brian J Druker, Susan Branford, et al.
Critical Reviews in Oncology/Hematology|January 11, 2014
Current management of CML patients: Summary of the Italian Consensus Meeting held in Rome, April 11-12, 2013Massimo Breccia, Giuliana Alimena, Michele Baccarani, et al.
Cancers|April 13, 2023
Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective StudyMarco Picardi, Claudia Giordano, Roberta Della Pepa, et al.
Frontiers in Oncology|March 9, 2023
Lamivudine 24-month-long prophylaxis is a safe and efficient choice for the prevention of hepatitis B virus reactivation in HBsAg-negative/HBcAb-positive patients with advanced DLBCL undergoing upfront R-CHOP-21Claudia Giordano, Marco Picardi, Novella Pugliese, et al.
American Journal of Blood Research|September 20, 2021
Accuracy of bone marrow histochemical TP53 expression compared to the detection of TP53 somatic mutations in patients with myelodysplastic syndromes harbouring a del5q cytogenetic abnormalityEsther N Oliva, Roberto Latagliata, Elena Sabattini, et al.
Pageof 26